Studies have shown [11]: Prevention of gastric lesions when co-administered with NSAIDs Healing of existing NSAID-induced damage Protection of both upper and lower GI tract Preservation of intestinal permeability This is particularly significant given that millions of people take NSAIDs regularly, often experiencing GI side effects
Greenough, M
In a separate analysis, lixisenatide reduced incident macroalbuminuria, while adjustments for baseline characteristics such as age, blood pressure and eGFR, as well as on trial HbA1c, blood pressure and weight, did not significantly attenuate the association [28]
L-arginine-induced AP was performed by administrating a single intraperitoneal injection of 4.0 g/kg body weight L-arginine monohydrochloride in 0.9% sodium chloride (pH7.0) as described previously
Germany Market Trends Germany is an important contributor to the European market for oral GLP-1 agonists
Collectively, these extra-hepatic effects create a favorable systemic metabolic environment that indirectly but substantially benefits hepatic steatosis and MASH